panel: cell therapies: essential requirements for near-term and long-term commercial success
Published 7 years ago • 399 plays • Length 38:41Download video MP4
Download video MP3
Similar videos
-
52:35
panel: cell therapy infrastructure & manufacturing requirements for commercialization
-
23:40
expediting the development of cell and gene therapy
-
50:13
panel: cell therapy manufacturing
-
1:05:49
panel: cell and gene therapies for chronic conditions
-
59:49
plenary session: gene therapy & gene-modified cell therapies
-
53:56
panel: cell and gene therapies for ophthalmologic diseases
-
45:51
cell therapy milestones in 2023
-
54:19
panel: cell and gene therapy for neurological product indications
-
52:32
panel: when does investing in cell and gene therapy make business sense?
-
16:25
fda’s efforts to advance the development and approval of cellular and gene therapies
-
58:25
panel: current realities of make vs. buy for cell & gene therapy manufacturing
-
1:02:39
a-cell: manufacturing of cell-based therapies
-
45:05
panel: cell therapy for solid tumors
-
54:48
panel: corporate partnering to build valuable, sustainable clinical pipelines in gene & cell therapy
-
1:31:36
readiness strategies for cell therapy commercial manufacturing workshop
-
1:11:29
panel: acceptance and uptake of cell and gene therapies: lessons learned and future focus
-
1:00:38
critical supply chain and logistics considerations for cell and gene therapy management
-
59:22
the importance of ethics in gene and cell therapy
-
53:04
plenary session: cell therapy commercialization today and preparing for the future